Free Trial

Exelon (EXC) Financials

Exelon logo
$46.74 -0.12 (-0.26%)
Closing price 04:00 PM Eastern
Extended Trading
$47.24 +0.50 (+1.08%)
As of 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Exelon

Annual Income Statements for Exelon

This table shows Exelon's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
1,697 1,121 3,779 2,005 2,936 1,963 1,706 2,170 2,328 2,460
Consolidated Net Income / (Loss)
1,669 1,196 3,869 2,079 3,028 1,954 1,829 2,171 2,328 2,460
Net Income / (Loss) Continuing Operations
0.00 32,514 3,869 2,079 3,028 1,099 1,616 2,054 2,328 2,460
Total Pre-Tax Income
3,330 1,973 3,775 2,225 3,985 1,092 1,654 2,403 2,702 2,667
Total Operating Income
2,748 34,530 4,388 3,891 4,374 2,191 2,682 3,315 4,023 4,319
Total Gross Profit
2,730 40,090 9,498 19,308 10,326 6,301 7,006 8,032 8,927 9,405
Total Revenue
11,052 62,684 33,558 35,978 34,438 16,663 17,938 19,078 21,727 23,028
Operating Revenue
11,052 62,684 33,558 35,978 34,438 16,663 17,938 19,078 21,727 23,028
Total Cost of Revenue
8,322 22,594 24,060 16,670 24,112 10,362 10,932 11,046 12,800 13,623
Operating Cost of Revenue
8,322 22,594 24,060 16,670 24,112 10,362 10,932 11,046 12,800 13,623
Total Operating Expenses
-18 5,560 5,110 15,417 5,952 4,110 4,324 4,717 4,904 5,086
Depreciation Expense
- 3,936 3,828 4,353 4,252 2,891 3,033 3,325 3,506 3,594
Other Operating Expenses / (Income)
0.00 1,576 1,518 11,120 1,731 1,232 1,291 1,390 1,408 1,504
Other Special Charges / (Income)
-18 48 -236 -56 -31 -13 0.00 2.00 -10 -12
Total Other Income / (Expense), net
-1,079 -1,239 -613 -1,666 -389 -1,099 -1,028 -912 -1,321 -1,652
Interest Expense
- 1,536 1,560 1,554 1,616 1,307 1,289 1,447 1,729 1,914
Other Income / (Expense), net
- 297 947 -112 1,227 208 261 535 408 262
Income Tax Expense
- 753 -126 118 774 -7.00 38 349 374 207
Net Income / (Loss) Discontinued Operations
- - - - - 855 213 117 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-28 75 90 74 92 -9.00 123 1.00 0.00 0.00
Weighted Average Basic Shares Outstanding
890M 924M 947M 967M 973M 976M 979M 986M 996M 1.00B
Weighted Average Diluted Shares Outstanding
893M 927M 949M 969M 974M 977M 980M 987M 997M 1.00B
Weighted Average Basic & Diluted Shares Outstanding
890M 924M 946.50M 966.30M 973M 2.56B 1.29B 1.30B 1.31B 1.31B
Cash Dividends to Common per Share
$1.24 $0.00 $1.31 $1.38 $1.45 $1.53 $1.53 $1.35 $1.44 $1.52

Quarterly Income Statements for Exelon

This table shows Exelon's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
676 - 669 343 700 616 658 448 707 647
Consolidated Net Income / (Loss)
676 - 669 343 700 616 658 448 707 647
Net Income / (Loss) Continuing Operations
676 - 669 343 700 616 658 448 707 647
Total Pre-Tax Income
768 - 803 416 767 716 721 494 757 695
Total Operating Income
1,011 - 1,106 704 1,123 1,090 1,114 913 1,196 1,096
Total Gross Profit
2,213 - 3,472 3,091 3,583 -1,219 3,633 3,369 3,771 -1,368
Total Revenue
4,845 - 5,563 4,818 5,980 5,366 6,043 5,361 6,154 5,470
Operating Revenue
4,845 - 5,563 4,818 5,980 5,366 6,043 5,361 6,154 5,470
Total Cost of Revenue
2,632 - 2,091 1,727 2,397 6,585 2,410 1,992 2,383 6,838
Operating Cost of Revenue
2,632 - 2,091 1,727 2,397 6,585 2,410 1,992 2,383 6,838
Total Operating Expenses
1,202 - 2,366 2,387 2,460 -2,309 2,519 2,463 2,575 -2,471
Depreciation Expense
825 - 860 866 890 890 879 894 908 913
Other Operating Expenses / (Income)
377 - 355 324 383 346 371 360 395 378
Total Other Income / (Expense), net
-243 - -303 -288 -356 -374 -393 -419 -439 -401
Interest Expense
365 - 412 427 437 453 468 483 496 467
Other Income / (Expense), net
122 - 109 139 81 79 75 64 57 66
Income Tax Expense
92 - 134 73 67 100 63 46 50 48
Weighted Average Basic Shares Outstanding
988M 986M 995M 995M 996M 996M 1B 1.00B 1.00B 1.00B
Weighted Average Diluted Shares Outstanding
989M 987M 996M 996M 997M 997M 1.00B 1.00B 1.00B 1.00B
Weighted Average Basic & Diluted Shares Outstanding
1.30B 1.30B 1.30B 1.30B 1.30B 1.31B 1.31B 1.31B 1.31B 1.31B

Annual Cash Flow Statements for Exelon

This table details how cash moves in and out of Exelon's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
4,624 -5,798 276 -3,841 -659 44 453 -529 11 -162
Net Cash From Operating Activities
7,616 8,461 7,480 4,303 6,659 4,235 3,012 4,870 4,703 5,569
Net Cash From Continuing Operating Activities
7,558 8,461 6,024 4,303 5,433 5,533 3,012 4,870 4,703 5,569
Net Income / (Loss) Continuing Operations
2,250 1,196 3,869 0.00 3,028 1,954 1,829 2,171 2,328 2,460
Consolidated Net Income / (Loss)
2,250 1,196 3,869 - 3,028 1,954 1,829 2,171 2,328 2,460
Depreciation Expense
3,987 5,576 5,427 5,971 5,780 6,527 7,573 3,533 3,506 3,596
Non-Cash Adjustments To Reconcile Net Income
1,643 2,138 -169 -1,217 1,027 553 -940 833 -4.00 708
Changes in Operating Assets and Liabilities, net
-322 -449 -1,647 -451 -3,176 -4,799 -5,450 -1,667 -1,127 -1,195
Net Cash From Investing Activities
-7,822 -15,450 -7,971 -7,925 -7,260 -4,336 -3,317 -6,990 -7,375 -7,042
Net Cash From Continuing Investing Activities
-7,822 -15,450 -7,971 -7,925 -7,260 -4,336 -3,317 -6,990 -7,375 -7,042
Purchase of Property, Plant & Equipment
-7,624 -8,553 -7,584 -7,594 -7,248 -8,048 -7,981 -7,147 -7,408 -7,097
Purchase of Investments
-7,147 -9,738 -8,113 -8,997 -10,087 -3,464 -6,673 -516 0.00 0.00
Sale of Property, Plant & Equipment
147 61 219 - 53 46 877 16 25 38
Sale and/or Maturity of Investments
6,895 9,496 7,845 8,762 10,051 3,341 6,532 488 0.00 0.00
Other Investing Activities, net
-53 207 -43 58 12 3,789 3,928 169 8.00 17
Net Cash From Financing Activities
4,830 1,191 767 -219 -58 145 758 1,591 2,683 1,311
Net Cash From Continuing Financing Activities
4,830 1,183 767 -219 -58 145 758 1,591 2,683 1,311
Repayment of Debt
-2,706 -2,836 -3,784 -1,895 -713 -6,415 -1,801 -2,689 -2,290 -2,215
Payment of Dividends
-1,105 -1,174 -1,236 -1,332 -1,408 -1,492 -2,382 -1,334 -1,433 -1,524
Issuance of Debt
6,709 4,956 4,091 2,903 1,951 8,007 4,861 7,609 6,225 4,859
Issuance of Common Equity
1,932 427 1,696 105 112 45 80 599 181 191
Other Financing Activities, net
0.00 0.00 - 0.00 0.00 0.00 0.00 -2,594 0.00 0.00

Quarterly Cash Flow Statements for Exelon

This table details how cash moves in and out of Exelon's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
701 -183 -7.00 -48 -88 154 207 227 -302 -294
Net Cash From Operating Activities
3,737 729 484 1,277 1,531 1,411 992 1,462 1,689 1,426
Net Cash From Continuing Operating Activities
3,737 729 484 1,277 1,531 1,411 992 1,462 1,689 1,426
Net Income / (Loss) Continuing Operations
1,739 432 669 343 699 617 658 448 707 647
Consolidated Net Income / (Loss)
- 432 669 343 699 617 658 448 707 647
Depreciation Expense
- 854 860 867 889 890 880 894 909 913
Non-Cash Adjustments To Reconcile Net Income
278 112 -25 -99 118 2.00 84 225 -20 419
Changes in Operating Assets and Liabilities, net
-959 -669 -1,020 166 -175 -98 -630 -105 93 -553
Net Cash From Investing Activities
-5,312 -2,004 -1,871 -1,804 -1,840 -1,860 -1,767 -1,700 -1,647 -1,928
Net Cash From Continuing Investing Activities
-5,312 -2,004 -1,871 -1,804 -1,840 -1,860 -1,767 -1,700 -1,647 -1,928
Purchase of Property, Plant & Equipment
- -1,968 -1,881 -1,804 -1,855 -1,868 -1,767 -1,699 -1,695 -1,936
Other Investing Activities, net
-133 -36 10 - 15 -17 -2.00 1.00 10 8.00
Net Cash From Financing Activities
2,276 1,092 1,380 479 221 603 982 465 -344 208
Net Cash From Continuing Financing Activities
2,276 1,092 1,380 479 221 603 982 465 -344 208
Repayment of Debt
-3,098 759 -2,197 -846 467 286 -1,423 -766 221 -247
Payment of Dividends
- -335 -358 -359 -357 -359 -381 -380 -381 -382
Issuance of Debt
5,801 658 3,925 1,675 100 525 2,775 1,600 -343 827
Issuance of Common Equity
572 10 10 9.00 11 151 11 11 159 10

Annual Balance Sheets for Exelon

This table presents Exelon's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
95,384 114,904 116,770 119,634 124,977 129,317 133,013 95,349 101,856 107,784
Total Current Assets
15,334 12,412 11,896 13,328 12,037 12,562 13,957 7,336 8,087 8,384
Cash & Equivalents
6,502 635 898 1,349 587 663 672 407 445 357
Restricted Cash
205 253 207 247 358 438 321 566 482 541
Accounts Receivable
912 5,359 5,577 5,863 6,223 4,700 2,865 3,561 3,361 3,754
Inventories, net
1,566 1,638 1,651 1,685 1,768 1,722 581 755 801 853
Prepaid Expenses
- - - - - - - - 413 494
Current Deferred & Refundable Income Taxes
0.00 1,250 0.00 0.00 0.00 0.00 - - 0.00 0.00
Other Current Assets
2,962 3,277 3,563 3,280 3,149 4,152 1,683 2,047 2,585 2,385
Plant, Property, & Equipment, net
57,439 71,555 74,202 76,707 80,233 82,584 64,558 69,076 73,593 78,182
Total Noncurrent Assets
22,405 30,937 30,672 29,599 32,707 34,171 54,498 18,937 20,176 21,218
Long-Term Investments
639 629 640 625 464 440 250 232 251 290
Noncurrent Note & Lease Receivables
0.00 - 0.00 0.00 0.00 0.00 0.00 2,897 3,232 4,026
Goodwill
2,672 6,677 6,677 6,677 6,677 6,677 6,630 6,630 6,630 6,630
Employee Benefit Assets
- - 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Other Noncurrent Operating Assets
19,094 23,631 23,355 22,297 25,566 27,054 9,109 9,178 10,063 10,272
Total Liabilities & Shareholders' Equity
95,384 114,904 116,770 119,634 124,977 129,317 133,013 95,349 101,856 107,784
Total Liabilities
68,062 87,292 84,583 86,587 90,404 94,449 98,218 70,605 76,101 80,863
Total Current Liabilities
9,118 13,457 10,798 11,404 14,185 12,771 16,111 10,611 9,901 9,611
Short-Term Debt
2,033 3,697 3,017 2,063 6,080 3,850 3,401 4,388 3,926 3,312
Accounts Payable
3,193 3,441 3,889 3,805 3,565 3,567 2,384 3,387 2,851 2,999
Accrued Expenses
2,376 3,460 1,837 2,112 1,981 2,078 1,137 1,226 1,375 1,468
Customer Deposits
0.00 - 0.00 0.00 0.00 - - - 411 446
Other Current Liabilities
1,516 2,700 2,055 2,647 2,559 2,901 1,249 1,610 1,338 1,386
Total Noncurrent Liabilities
58,854 73,835 73,785 75,183 76,219 81,678 82,107 59,994 66,200 71,252
Long-Term Debt
23,645 31,575 32,176 34,075 31,329 35,093 30,749 35,662 40,082 43,337
Asset Retirement Reserve & Litigation Obligation
13,807 14,336 21,041 20,409 22,031 22,993 9,899 9,381 9,843 10,499
Noncurrent Deferred & Payable Income Tax Liabilities
13,776 18,138 11,235 11,321 12,351 13,035 10,611 11,250 11,956 12,793
Noncurrent Employee Benefit Liabilities
5,003 6,096 5,829 5,916 6,323 6,514 2,862 1,616 2,098 2,217
Other Noncurrent Operating Liabilities
1,982 3,049 3,504 3,462 4,185 4,043 2,310 2,085 2,221 2,406
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
27,294 27,612 32,187 33,047 34,573 34,868 34,795 24,744 25,755 26,921
Total Preferred & Common Equity
25,793 25,837 29,896 30,741 32,224 32,585 34,393 24,744 25,755 26,921
Total Common Equity
25,793 25,837 29,896 30,741 32,224 32,585 34,393 24,744 0.00 0.00
Common Stock
18,676 18,794 18,964 19,116 19,274 19,373 20,324 20,908 21,114 21,338
Retained Earnings
12,068 12,030 14,081 14,743 16,267 16,735 16,942 4,597 5,490 6,426
Treasury Stock
-2,327 -2,327 -123 -123 -123 -123 -123 -123 -123 -123
Accumulated Other Comprehensive Income / (Loss)
-2,624 -2,660 -3,026 -2,995 -3,194 -3,400 -2,750 -638 -726 -720

Quarterly Balance Sheets for Exelon

This table presents Exelon's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Total Assets
93,455 95,349 98,080 99,259 101,856 103,211 105,113 106,070 107,784
Total Current Assets
7,055 7,336 7,542 7,519 8,087 8,212 8,557 8,023 8,384
Cash & Equivalents
446 407 399 300 445 720 934 616 357
Restricted Cash
744 566 435 435 482 489 530 552 541
Accounts Receivable
3,430 3,561 3,125 3,314 3,361 3,585 3,709 3,660 3,754
Inventories, net
757 755 710 762 801 788 824 855 853
Prepaid Expenses
- - - - 413 - - - 494
Current Deferred & Refundable Income Taxes
0.00 - 0.00 - 0.00 0.00 0.00 0.00 0.00
Other Current Assets
1,678 2,047 2,968 2,708 2,585 2,630 2,560 2,340 2,385
Plant, Property, & Equipment, net
67,572 69,076 71,300 72,458 73,593 74,604 75,646 76,661 78,182
Total Noncurrent Assets
18,828 18,937 19,238 19,282 20,176 20,395 20,910 21,386 21,218
Long-Term Investments
230 232 238 246 251 263 270 279 290
Noncurrent Note & Lease Receivables
2,658 2,897 3,120 2,923 3,232 3,382 3,840 4,322 4,026
Goodwill
6,630 6,630 6,630 6,630 6,630 6,630 6,630 6,630 6,630
Employee Benefit Assets
- 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00
Other Noncurrent Operating Assets
9,310 9,178 9,250 9,483 10,063 10,120 10,170 10,155 10,272
Total Liabilities & Shareholders' Equity
93,455 95,349 98,080 99,259 101,856 103,211 105,113 106,070 107,784
Total Liabilities
68,873 70,605 73,001 73,789 76,101 77,150 78,961 79,448 80,863
Total Current Liabilities
8,717 10,611 7,936 8,800 9,901 7,975 8,275 7,384 9,611
Short-Term Debt
2,990 4,388 2,741 3,374 3,926 2,709 2,762 1,985 3,312
Accounts Payable
2,698 3,387 0.00 2,689 2,851 2,819 2,815 2,653 2,999
Accrued Expenses
1,213 1,226 1,220 1,315 1,375 1,076 1,241 1,284 1,468
Customer Deposits
- - - - 411 419 425 432 446
Other Current Liabilities
1,816 1,610 1,464 1,422 1,338 952 1,032 1,030 1,386
Total Noncurrent Liabilities
60,156 59,994 65,454 64,989 66,200 69,175 70,686 72,064 71,252
Long-Term Debt
35,283 35,662 40,271 39,821 40,082 42,661 43,429 44,091 43,337
Asset Retirement Reserve & Litigation Obligation
9,110 9,381 9,679 9,505 9,843 9,976 10,470 10,852 10,499
Noncurrent Deferred & Payable Income Tax Liabilities
11,113 11,250 11,547 11,792 11,956 12,199 12,358 12,551 12,793
Noncurrent Employee Benefit Liabilities
2,162 1,616 1,571 1,600 2,098 2,092 2,086 2,081 2,217
Other Noncurrent Operating Liabilities
2,488 2,085 2,386 2,271 2,221 2,247 2,343 2,489 2,406
Commitments & Contingencies
0.00 0.00 0.00 - 0.00 - - - 0.00
Total Equity & Noncontrolling Interests
24,582 24,744 25,079 25,470 25,755 26,061 26,152 26,622 26,921
Total Preferred & Common Equity
24,582 24,744 25,079 25,470 25,755 26,061 26,152 26,622 26,921
Total Common Equity
24,582 24,744 25,079 25,470 0.00 26,061 26,152 26,622 0.00
Common Stock
20,895 20,908 20,941 20,956 21,114 21,129 21,152 21,320 21,338
Retained Earnings
4,502 4,597 4,891 5,233 5,490 5,767 5,835 6,161 6,426
Treasury Stock
-123 -123 -123 -123 -123 -123 -123 -123 -123
Accumulated Other Comprehensive Income / (Loss)
-692 -638 -630 -596 -726 -712 -712 -736 -720

Annual Metrics and Ratios for Exelon

This table displays calculated financial ratios and metrics derived from Exelon's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
-92.15% 467.17% -46.46% 7.21% -4.28% -51.61% 7.65% 6.36% 13.89% 5.99%
EBITDA Growth
-36.89% 499.90% -73.36% -9.40% 16.73% -21.57% 17.81% -29.79% 7.50% 3.02%
EBIT Growth
-59.61% 1,167.36% -84.68% -29.17% 48.21% -57.17% 22.68% 30.82% 15.09% 3.39%
NOPAT Growth
-54.54% 676.98% -78.76% -18.74% -4.35% -37.44% 18.84% 8.13% 22.33% 14.93%
Net Income Growth
-69.38% -28.34% 223.50% -46.27% 45.65% -35.47% -6.40% 18.70% 7.23% 5.67%
EPS Growth
35.11% -52.36% 228.93% -47.99% 45.65% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
70.88% 11.10% -11.59% -42.47% 54.75% -36.40% -28.88% 61.69% -3.43% 18.41%
Free Cash Flow Firm Growth
213.74% -72.08% -51.00% 132.79% -108.52% 615.73% 1,672.01% -129.90% 73.54% 112.21%
Invested Capital Growth
-10.51% 44.60% 5.58% 1.83% 5.59% 1.58% -23.31% 15.67% 7.86% 5.54%
Revenue Q/Q Growth
-91.18% 87.60% -16.78% 1.20% -1.33% -49.91% 24.49% 0.00% 0.00% 0.45%
EBITDA Q/Q Growth
-54.74% 43.58% -37.84% -10.73% 8.58% 3.98% 107.79% 82.39% 128.73% 0.20%
EBIT Q/Q Growth
-74.88% 50.94% -54.58% -24.16% 21.00% -43.66% 116.40% 0.00% 0.00% -0.15%
NOPAT Q/Q Growth
-64.12% 32.19% -46.09% -27.26% 2.13% -29.52% 213.88% 0.00% 0.00% 2.22%
Net Income Q/Q Growth
105.32% 79.58% 78.21% -46.92% 30.46% -16.03% -2.51% 0.00% 0.00% 1.28%
EPS Q/Q Growth
0.00% 0.00% 80.09% -46.79% 30.46% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
49.04% -9.07% 10.47% -49.27% 5,992.92% -0.45% -64.66% 61.69% 16.96% 0.27%
Free Cash Flow Firm Q/Q Growth
-83.43% 105.51% -82.05% -4.76% -125.52% -12.54% -74.47% 91.14% 75.52% -43.47%
Invested Capital Q/Q Growth
617.49% 0.83% 2.36% 0.38% 1.98% 0.85% 1,544.02% 3.51% 1.33% 1.59%
Profitability Metrics
- - - - - - - - - -
Gross Margin
24.70% 63.96% 28.30% 53.67% 29.98% 37.81% 39.06% 42.10% 41.09% 40.84%
EBITDA Margin
60.94% 64.46% 32.07% 27.10% 33.05% 53.57% 58.62% 38.70% 36.53% 35.51%
Operating Margin
24.86% 55.09% 13.08% 10.81% 12.70% 13.15% 14.95% 17.38% 18.52% 18.76%
EBIT Margin
24.86% 55.56% 15.90% 10.50% 16.26% 14.40% 16.41% 20.18% 20.39% 19.89%
Profit (Net Income) Margin
15.10% 1.91% 11.53% 5.78% 8.79% 11.73% 10.20% 11.38% 10.71% 10.68%
Tax Burden Percent
50.12% 60.62% 102.49% 93.44% 75.98% 178.94% 110.58% 90.35% 86.16% 92.24%
Interest Burden Percent
121.18% 5.67% 70.76% 58.88% 71.15% 45.52% 56.20% 62.42% 60.98% 58.22%
Effective Tax Rate
0.00% 38.17% -3.34% 5.30% 19.42% -0.64% 2.30% 14.52% 13.84% 7.76%
Return on Invested Capital (ROIC)
6.04% 40.61% 7.10% 5.56% 5.13% 3.10% 4.14% 4.78% 5.24% 5.65%
ROIC Less NNEP Spread (ROIC-NNEP)
0.40% -39.61% 5.14% 0.79% 3.71% 2.41% 1.36% 2.53% 2.46% 2.20%
Return on Net Nonoperating Assets (RNNOA)
0.29% -36.25% 5.84% 0.81% 3.83% 2.53% 1.11% 2.51% 3.98% 3.69%
Return on Equity (ROE)
6.32% 4.36% 12.94% 6.37% 8.96% 5.63% 5.25% 7.29% 9.22% 9.34%
Cash Return on Invested Capital (CROIC)
17.13% 4.14% 1.67% 3.75% -0.31% 1.53% 30.53% -9.75% -2.31% 0.27%
Operating Return on Assets (OROA)
3.30% 33.12% 4.61% 3.20% 4.58% 1.89% 2.24% 3.37% 4.49% 4.37%
Return on Assets (ROA)
2.00% 1.14% 3.34% 1.76% 2.48% 1.54% 1.39% 1.90% 2.36% 2.35%
Return on Common Equity (ROCE)
6.12% 4.10% 12.06% 5.92% 8.34% 5.25% 5.05% 7.24% 4.52% 0.00%
Return on Equity Simple (ROE_SIMPLE)
6.47% 4.63% 12.94% 6.76% 9.40% 6.00% 5.32% 8.77% 9.04% 9.14%
Net Operating Profit after Tax (NOPAT)
2,748 21,352 4,534 3,685 3,524 2,205 2,620 2,834 3,466 3,984
NOPAT Margin
24.86% 34.06% 13.51% 10.24% 10.23% 13.23% 14.61% 14.85% 15.95% 17.30%
Net Nonoperating Expense Percent (NNEP)
5.64% 80.22% 1.96% 4.78% 1.42% 0.69% 2.78% 2.25% 2.79% 3.45%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 4.37% 4.97% 5.42%
Cost of Revenue to Revenue
75.30% 36.04% 71.70% 46.33% 70.02% 62.19% 60.94% 57.90% 58.91% 59.16%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
-0.16% 8.87% 15.23% 42.85% 17.28% 24.67% 24.11% 24.72% 22.57% 22.09%
Earnings before Interest and Taxes (EBIT)
2,748 34,827 5,335 3,779 5,601 2,399 2,943 3,850 4,431 4,581
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
6,735 40,403 10,762 9,750 11,381 8,926 10,516 7,383 7,937 8,177
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.96 1.29 1.32 1.53 1.53 1.46 1.96 2.10 0.00 0.00
Price to Tangible Book Value (P/TBV)
1.08 1.74 1.70 1.95 1.93 1.83 2.42 2.87 0.00 0.00
Price to Revenue (P/Rev)
2.25 0.53 1.18 1.31 1.43 2.85 3.75 2.73 2.06 2.14
Price to Earnings (P/E)
14.66 29.75 10.47 23.45 16.77 24.17 39.44 23.99 19.27 20.06
Dividend Yield
6.07% 4.66% 4.20% 3.74% 3.77% 4.13% 2.92% 3.37% 4.18% 4.04%
Earnings Yield
6.82% 3.36% 9.55% 4.26% 5.96% 4.14% 2.54% 4.17% 5.19% 4.99%
Enterprise Value to Invested Capital (EV/IC)
1.04 1.11 1.15 1.25 1.24 1.22 1.83 1.43 1.28 1.31
Enterprise Value to Revenue (EV/Rev)
4.05 1.10 2.24 2.31 2.54 5.23 5.61 4.77 4.04 4.12
Enterprise Value to EBITDA (EV/EBITDA)
6.64 1.70 7.00 8.54 7.70 9.76 9.57 12.31 11.05 11.59
Enterprise Value to EBIT (EV/EBIT)
16.27 1.98 14.11 22.03 15.64 36.32 34.18 23.61 19.79 20.69
Enterprise Value to NOPAT (EV/NOPAT)
16.27 3.23 16.60 22.59 24.85 39.52 38.39 32.08 25.30 23.80
Enterprise Value to Operating Cash Flow (EV/OCF)
5.87 8.14 10.07 19.35 13.15 20.58 33.40 18.67 18.64 17.02
Enterprise Value to Free Cash Flow (EV/FCFF)
5.74 31.65 70.60 33.53 0.00 79.87 5.20 0.00 0.00 507.56
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.94 1.28 1.09 1.09 1.08 1.12 0.98 1.62 1.71 1.73
Long-Term Debt to Equity
0.87 1.14 1.00 1.03 0.91 1.01 0.88 1.44 1.56 1.61
Financial Leverage
0.72 0.92 1.14 1.03 1.03 1.05 0.82 0.99 1.62 1.68
Leverage Ratio
3.16 3.83 3.87 3.62 3.62 3.66 3.77 3.84 3.91 3.98
Compound Leverage Factor
3.83 0.22 2.74 2.13 2.57 1.67 2.12 2.39 2.38 2.32
Debt to Total Capital
48.47% 56.09% 52.23% 52.23% 51.97% 52.76% 49.53% 61.81% 63.08% 63.41%
Short-Term Debt to Total Capital
3.84% 5.88% 4.48% 2.98% 8.45% 5.22% 4.93% 6.77% 5.63% 4.50%
Long-Term Debt to Total Capital
44.64% 50.21% 47.75% 49.25% 43.52% 47.54% 44.60% 55.04% 57.45% 58.91%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.83% 2.82% 3.40% 3.33% 3.26% 3.09% 0.58% 0.00% 0.00% 0.00%
Common Equity to Total Capital
48.69% 41.09% 44.37% 44.43% 44.77% 44.15% 49.88% 38.19% 0.00% 0.00%
Debt to EBITDA
3.81 0.87 3.27 3.71 3.29 4.36 3.25 5.42 5.54 5.70
Net Debt to EBITDA
2.72 0.84 3.11 3.48 3.16 4.19 3.13 5.26 5.40 5.56
Long-Term Debt to EBITDA
3.51 0.78 2.99 3.49 2.75 3.93 2.92 4.83 5.05 5.30
Debt to NOPAT
9.34 1.65 7.76 9.81 10.61 17.66 13.03 14.13 12.70 11.71
Net Debt to NOPAT
6.67 1.58 7.38 9.21 10.21 16.96 12.56 13.71 12.36 11.41
Long-Term Debt to NOPAT
8.60 1.48 7.10 9.25 8.89 15.91 11.73 12.59 11.56 10.88
Altman Z-Score
0.69 1.91 0.90 0.92 0.91 0.67 0.78 0.80 0.76 0.79
Noncontrolling Interest Sharing Ratio
3.21% 5.97% 6.80% 7.05% 6.88% 6.67% 3.85% 0.68% 51.00% 100.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.68 0.92 1.10 1.17 0.85 0.98 0.87 0.69 0.82 0.87
Quick Ratio
0.81 0.45 0.60 0.63 0.48 0.41 0.22 0.37 0.38 0.43
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
7,795 2,177 1,066 2,483 -212 1,091 19,333 -5,781 -1,530 187
Operating Cash Flow to CapEx
101.86% 99.64% 101.56% 56.66% 92.55% 52.92% 42.40% 68.29% 63.70% 78.89%
Free Cash Flow to Firm to Interest Expense
0.00 1.42 0.68 1.60 -0.13 0.83 15.00 -4.00 -0.88 0.10
Operating Cash Flow to Interest Expense
0.00 5.51 4.79 2.77 4.12 3.24 2.34 3.37 2.72 2.91
Operating Cash Flow Less CapEx to Interest Expense
0.00 -0.02 0.07 -2.12 -0.33 -2.88 -3.17 -1.56 -1.55 -0.78
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.13 0.60 0.29 0.30 0.28 0.13 0.14 0.17 0.22 0.22
Accounts Receivable Turnover
0.00 19.99 6.14 6.29 5.70 3.05 4.74 5.94 6.28 6.47
Inventory Turnover
5.25 14.10 14.63 9.99 13.97 5.94 9.49 16.54 16.45 16.47
Fixed Asset Turnover
0.20 0.97 0.46 0.48 0.44 0.20 0.24 0.29 0.30 0.30
Accounts Payable Turnover
4.92 6.81 6.56 4.33 6.54 2.91 3.67 3.83 4.10 4.66
Days Sales Outstanding (DSO)
0.00 18.26 59.47 58.03 64.05 119.63 76.97 61.47 58.14 56.39
Days Inventory Outstanding (DIO)
69.50 25.88 24.95 36.52 26.14 61.47 38.45 22.07 22.19 22.16
Days Payable Outstanding (DPO)
74.23 53.59 55.60 84.23 55.78 125.61 99.35 95.35 88.94 78.37
Cash Conversion Cycle (CCC)
-4.74 -9.45 28.82 10.32 34.40 55.49 16.07 -11.80 -8.61 0.18
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
42,992 62,167 65,635 66,837 70,573 71,687 54,974 63,589 68,585 72,382
Invested Capital Turnover
0.24 1.19 0.53 0.54 0.50 0.23 0.28 0.32 0.33 0.33
Increase / (Decrease) in Invested Capital
-5,047 19,175 3,468 1,202 3,736 1,114 -16,713 8,615 4,996 3,797
Enterprise Value (EV)
44,709 68,879 75,289 83,250 87,581 87,140 100,590 90,910 87,684 94,803
Market Capitalization
24,876 33,349 39,550 47,027 49,232 47,455 67,281 52,065 44,854 49,342
Book Value per Share
$21.19 $21.02 $23.60 $24.15 $25.21 $25.42 $26.78 $19.04 $0.00 $0.00
Tangible Book Value per Share
$19.00 $15.59 $18.33 $18.90 $19.99 $20.22 $21.62 $13.94 ($5.09) ($5.06)
Total Capital
52,972 62,884 67,380 69,185 71,982 73,811 68,945 64,794 69,763 73,570
Total Debt
25,678 35,272 35,193 36,138 37,409 38,943 34,150 40,050 44,008 46,649
Total Long-Term Debt
23,645 31,575 32,176 34,075 31,329 35,093 30,749 35,662 40,082 43,337
Net Debt
18,332 33,755 33,448 33,917 36,000 37,402 32,907 38,845 42,830 45,461
Capital Expenditures (CapEx)
7,477 8,492 7,365 7,594 7,195 8,002 7,104 7,131 7,383 7,059
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,542 1,764 3,010 2,391 2,987 2,540 254 140 1,185 1,187
Debt-free Net Working Capital (DFNWC)
8,249 2,652 4,115 3,987 3,932 3,641 1,247 1,113 2,112 2,085
Net Working Capital (NWC)
6,216 -1,045 1,098 1,924 -2,148 -209 -2,154 -3,275 -1,814 -1,227
Net Nonoperating Expense (NNE)
1,079 20,156 665 1,606 496 251 791 663 1,138 1,524
Net Nonoperating Obligations (NNO)
15,698 34,555 33,448 33,790 36,000 36,819 20,179 38,845 42,830 45,461
Total Depreciation and Amortization (D&A)
3,987 5,576 5,427 5,971 5,780 6,527 7,573 3,533 3,506 3,596
Debt-free, Cash-free Net Working Capital to Revenue
13.95% 2.81% 8.97% 6.65% 8.67% 15.24% 1.42% 0.73% 5.45% 5.15%
Debt-free Net Working Capital to Revenue
74.64% 4.23% 12.26% 11.08% 11.42% 21.85% 6.95% 5.83% 9.72% 9.05%
Net Working Capital to Revenue
56.24% -1.67% 3.27% 5.35% -6.24% -1.25% -12.01% -17.17% -8.35% -5.33%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $2.83 $1.48 $2.15 $1.43 $1.74 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
1.25B 1.30B 1.33B 1.36B 1.37B 1.37B 979M 986M 996M 1.00B
Adjusted Diluted Earnings per Share
$0.00 $0.87 $2.83 $1.47 $2.14 $1.43 $1.74 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
1.25B 1.30B 1.33B 1.36B 1.37B 1.37B 980M 987M 997M 1.00B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.25B 2.09B 2.14B 1.79B 0.00 3.60B 1.29B 1.30B 1.31B 1.31B
Normalized Net Operating Profit after Tax (NOPAT)
1,911 21,381 2,906 3,632 3,499 1,525 2,620 2,835 3,458 3,973
Normalized NOPAT Margin
17.29% 34.11% 8.66% 10.09% 10.16% 9.15% 14.61% 14.86% 15.91% 17.25%
Pre Tax Income Margin
30.13% 3.15% 11.25% 6.18% 11.57% 6.55% 9.22% 12.60% 12.44% 11.58%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 22.67 3.42 2.43 3.47 1.84 2.28 2.66 2.56 2.39
NOPAT to Interest Expense
0.00 13.90 2.91 2.37 2.18 1.69 2.03 1.96 2.00 2.08
EBIT Less CapEx to Interest Expense
0.00 17.15 -1.30 -2.46 -0.99 -4.29 -3.23 -2.27 -1.71 -1.29
NOPAT Less CapEx to Interest Expense
0.00 8.37 -1.81 -2.52 -2.27 -4.44 -3.48 -2.97 -2.27 -1.61
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
66.21% 98.16% 31.95% 64.07% 46.50% 76.36% 130.24% 61.45% 61.56% 61.95%
Augmented Payout Ratio
66.21% 98.16% 31.95% 64.07% 46.50% 76.36% 130.24% 61.45% 61.56% 61.95%

Quarterly Metrics and Ratios for Exelon

This table displays calculated financial ratios and metrics derived from Exelon's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
-0.37% 0.00% 0.00% 0.00% 23.43% 0.00% 8.63% 11.27% 2.91% 1.94%
EBITDA Growth
-31.06% -65.07% 0.00% 0.00% 6.89% 141.10% -0.29% 9.42% 3.30% 0.78%
EBIT Growth
38.85% -100.00% 0.00% 0.00% 6.27% 0.00% -2.14% 15.90% 4.07% -0.60%
NOPAT Growth
26.73% -100.00% 0.00% 0.00% 15.17% 0.00% 10.33% 42.64% 8.99% 8.80%
Net Income Growth
-45.00% 0.00% 0.00% 2,958.33% 3.55% 0.00% -1.64% 30.61% 1.00% 5.03%
EPS Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1.49% 32.35% 0.00% 0.00%
Operating Cash Flow Growth
24.44% 164.57% 0.00% 0.00% -59.03% 93.55% 104.96% 14.49% 10.32% 1.06%
Free Cash Flow Firm Growth
-185.13% -146.59% 0.00% -194.33% 91.88% 52.89% 0.00% 99.08% 53.10% 31.58%
Invested Capital Growth
1,713.74% 15.67% 0.00% 0.00% 10.17% 7.86% 0.00% 2.11% 5.27% 5.54%
Revenue Q/Q Growth
0.00% 0.00% 0.00% -13.39% 24.12% -10.27% 12.62% -11.29% 14.79% -11.11%
EBITDA Q/Q Growth
0.00% -56.38% 142.97% -17.59% 22.40% -1.62% 0.49% -9.57% 15.55% -4.02%
EBIT Q/Q Growth
0.00% -100.00% 0.00% -30.62% 42.82% -2.91% 1.71% -17.83% 28.25% -7.26%
NOPAT Q/Q Growth
0.00% -100.00% 0.00% -37.00% 76.57% -8.50% 8.41% -18.56% 34.91% -8.66%
Net Income Q/Q Growth
5,733.33% 0.00% 0.00% -48.73% 104.08% -12.00% 6.82% -31.91% 57.81% -8.49%
EPS Q/Q Growth
0.00% 0.00% 0.00% -49.25% 105.88% -11.43% 6.45% -31.82% 55.56% 0.00%
Operating Cash Flow Q/Q Growth
0.00% -80.49% -33.61% 163.84% 19.89% -7.84% -29.70% 47.38% 15.53% -15.57%
Free Cash Flow Firm Q/Q Growth
-188.53% 86.61% 100.00% 0.00% 92.38% 22.32% -1,598.83% 99.08% -287.65% -13.33%
Invested Capital Q/Q Growth
0.00% 3.51% -100.00% 0.00% -2.12% 1.33% 2.00% 0.93% 0.91% 1.59%
Profitability Metrics
- - - - - - - - - -
Gross Margin
45.68% 0.00% 62.41% 64.16% 59.92% -22.72% 60.12% 62.84% 61.28% -25.01%
EBITDA Margin
40.41% 0.00% 37.30% 35.49% 35.00% 38.37% 34.24% 34.90% 35.13% 37.93%
Operating Margin
20.87% 0.00% 19.88% 14.61% 18.78% 20.31% 18.43% 17.03% 19.43% 20.04%
EBIT Margin
23.38% 0.00% 21.84% 17.50% 20.13% 21.79% 19.68% 18.22% 20.36% 21.24%
Profit (Net Income) Margin
13.95% 0.00% 12.03% 7.12% 11.71% 11.48% 10.89% 8.36% 11.49% 11.83%
Tax Burden Percent
88.02% 0.00% 83.31% 82.45% 91.26% 86.03% 91.26% 90.69% 93.40% 93.09%
Interest Burden Percent
67.78% 0.00% 66.09% 49.35% 63.70% 61.25% 60.64% 50.56% 60.42% 59.81%
Effective Tax Rate
11.98% 0.00% 16.69% 17.55% 8.74% 13.97% 8.74% 9.31% 6.61% 6.91%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 5.75% 10.68% 5.03% 5.99% 6.09%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 4.96% 9.05% 4.17% 5.05% 5.25%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 8.02% 15.24% 7.21% 8.41% 8.80%
Return on Equity (ROE)
0.00% 0.00% 0.00% 0.00% 0.00% 13.76% 25.92% 12.23% 14.40% 14.89%
Cash Return on Invested Capital (CROIC)
-106.20% -9.75% 0.00% -200.00% -9.68% -2.31% -189.81% 3.36% 0.48% 0.27%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% 4.80% 8.47% 4.08% 4.55% 4.67%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% 2.53% 4.69% 1.87% 2.57% 2.60%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 0.00% 0.00% 6.74% 25.92% 12.23% 14.40% 0.00%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 8.89% 9.26% 9.12% 0.00%
Net Operating Profit after Tax (NOPAT)
890 0.00 921 580 1,025 938 1,017 828 1,117 1,020
NOPAT Margin
18.37% 0.00% 16.56% 12.05% 17.14% 17.48% 16.82% 15.44% 18.15% 18.65%
Net Nonoperating Expense Percent (NNEP)
1.31% 0.00% 0.00% 1.08% 0.82% 0.79% 1.63% 0.86% 0.94% 0.85%
Return On Investment Capital (ROIC_SIMPLE)
- 0.00% - - - 1.34% - - - 1.39%
Cost of Revenue to Revenue
54.32% 0.00% 37.59% 35.84% 40.08% 122.72% 39.88% 37.16% 38.72% 125.01%
SG&A Expenses to Revenue
0.00% 0.00% 20.69% 24.84% 19.85% 0.00% 21.03% 22.55% 20.72% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
24.81% 0.00% 42.53% 49.54% 41.14% -43.03% 41.68% 45.94% 41.84% -45.17%
Earnings before Interest and Taxes (EBIT)
1,133 0.00 1,215 843 1,204 1,169 1,189 977 1,253 1,162
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,958 854 2,075 1,710 2,093 2,059 2,069 1,871 2,162 2,075
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.82 2.10 0.00 2.01 1.85 0.00 1.84 1.71 1.99 0.00
Price to Tangible Book Value (P/TBV)
2.49 2.87 0.00 2.73 2.51 0.00 2.47 2.29 2.65 0.00
Price to Revenue (P/Rev)
0.00 2.73 0.00 0.00 0.00 2.06 2.16 1.97 2.31 2.14
Price to Earnings (P/E)
0.00 23.99 0.00 0.00 0.00 19.27 20.68 18.47 21.81 20.06
Dividend Yield
3.70% 3.37% 3.47% 3.60% 3.90% 4.18% 3.97% 4.32% 3.70% 4.04%
Earnings Yield
0.00% 4.17% 0.00% 0.00% 0.00% 5.19% 4.84% 5.41% 4.58% 4.99%
Enterprise Value to Invested Capital (EV/IC)
1.33 1.43 0.00 1.34 1.32 1.28 1.31 1.26 1.37 1.31
Enterprise Value to Revenue (EV/Rev)
0.00 4.77 0.00 0.00 0.00 4.04 4.13 3.92 4.26 4.12
Enterprise Value to EBITDA (EV/EBITDA)
20.15 12.31 0.00 0.00 25.78 11.05 11.58 11.02 11.96 11.59
Enterprise Value to EBIT (EV/EBIT)
0.00 23.61 0.00 0.00 0.00 19.79 20.84 19.65 21.27 20.69
Enterprise Value to NOPAT (EV/NOPAT)
0.00 32.08 0.00 0.00 0.00 25.30 25.76 23.44 25.04 23.80
Enterprise Value to Operating Cash Flow (EV/OCF)
27.08 18.67 0.00 14.83 22.25 18.64 17.62 16.53 17.57 17.02
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 38.02 295.41 507.56
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
1.56 1.62 0.00 1.72 1.70 1.71 1.74 1.77 1.73 1.73
Long-Term Debt to Equity
1.44 1.44 0.00 1.61 1.56 1.56 1.64 1.66 1.66 1.61
Financial Leverage
1.32 0.99 0.00 1.76 1.58 1.62 1.68 1.73 1.67 1.68
Leverage Ratio
3.76 3.84 0.00 3.91 3.85 3.91 3.96 3.97 3.94 3.98
Compound Leverage Factor
2.55 0.00 0.00 1.93 2.45 2.39 2.40 2.01 2.38 2.38
Debt to Total Capital
60.89% 61.81% 0.00% 63.17% 62.91% 63.08% 63.52% 63.85% 63.38% 63.41%
Short-Term Debt to Total Capital
4.76% 6.77% 0.00% 4.03% 4.91% 5.63% 3.79% 3.82% 2.73% 4.50%
Long-Term Debt to Total Capital
56.13% 55.04% 0.00% 59.14% 57.99% 57.45% 59.72% 60.03% 60.65% 58.91%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
39.11% 38.19% 0.00% 36.83% 37.09% 0.00% 36.48% 36.15% 36.62% 0.00%
Debt to EBITDA
9.45 5.42 0.00 0.00 12.45 5.54 5.72 5.71 5.65 5.70
Net Debt to EBITDA
9.10 5.26 0.00 0.00 12.17 5.40 5.54 5.49 5.47 5.56
Long-Term Debt to EBITDA
8.72 4.83 0.00 0.00 11.48 5.05 5.38 5.37 5.40 5.30
Debt to NOPAT
0.00 14.13 0.00 0.00 0.00 12.70 12.73 12.14 11.82 11.71
Net Debt to NOPAT
0.00 13.71 0.00 0.00 0.00 12.36 12.31 11.68 11.45 11.41
Long-Term Debt to NOPAT
0.00 12.59 0.00 0.00 0.00 11.56 11.97 11.41 11.31 10.88
Altman Z-Score
0.48 0.67 0.00 0.51 0.48 0.66 0.71 0.67 0.74 0.69
Noncontrolling Interest Sharing Ratio
1.64% 0.00% 0.00% 0.00% 0.00% 51.00% 0.00% 0.00% 0.00% 100.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.81 0.69 0.00 0.95 0.85 0.82 1.03 1.03 1.09 0.87
Quick Ratio
0.44 0.37 0.00 0.43 0.41 0.38 0.54 0.56 0.58 0.43
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-64,352 -8,615 0.00 -68,569 -5,224 -4,058 -68,942 -632 -2,450 -2,777
Operating Cash Flow to CapEx
0.00% 37.04% 25.73% 70.79% 82.53% 76.56% 56.20% 86.05% 99.65% 73.66%
Free Cash Flow to Firm to Interest Expense
-176.31 0.00 0.00 -160.58 -11.95 -8.96 -147.31 -1.31 -4.94 -5.95
Operating Cash Flow to Interest Expense
10.24 0.00 1.17 2.99 3.50 3.11 2.12 3.03 3.41 3.05
Operating Cash Flow Less CapEx to Interest Expense
10.24 0.00 -3.39 -1.23 -0.74 -0.95 -1.65 -0.49 -0.01 -1.09
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 0.17 0.00 0.00 0.00 0.22 0.43 0.22 0.22 0.22
Accounts Receivable Turnover
0.00 5.94 0.00 0.00 0.00 6.28 0.00 6.66 6.57 6.47
Inventory Turnover
0.00 16.54 0.00 0.00 0.00 16.45 0.00 17.45 16.54 16.47
Fixed Asset Turnover
0.00 0.29 0.00 0.00 0.00 0.30 0.00 0.31 0.31 0.30
Accounts Payable Turnover
0.00 3.83 0.00 0.00 0.00 4.10 0.00 0.00 5.01 4.66
Days Sales Outstanding (DSO)
0.00 61.47 0.00 0.00 0.00 58.14 0.00 54.82 55.52 56.39
Days Inventory Outstanding (DIO)
0.00 22.07 0.00 0.00 0.00 22.19 0.00 20.92 22.07 22.16
Days Payable Outstanding (DPO)
0.00 95.35 0.00 0.00 0.00 88.94 0.00 0.00 72.92 78.37
Cash Conversion Cycle (CCC)
0.00 -11.80 0.00 0.00 0.00 -8.61 0.00 75.74 4.67 0.18
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
61,435 63,589 0.00 69,149 67,684 68,585 69,959 70,609 71,251 72,382
Invested Capital Turnover
0.00 0.32 0.00 0.00 0.00 0.33 0.63 0.33 0.33 0.33
Increase / (Decrease) in Invested Capital
65,242 8,615 0.00 69,149 6,249 4,996 69,959 1,460 3,567 3,797
Enterprise Value (EV)
81,557 90,910 51,417 92,373 89,454 87,684 91,819 89,202 97,609 94,803
Market Capitalization
44,704 52,065 51,417 50,433 47,240 44,854 47,921 44,745 52,980 49,342
Book Value per Share
$19.11 $19.04 $0.00 $25.21 $19.57 $0.00 $26.06 $20.02 $20.38 $0.00
Tangible Book Value per Share
$13.96 $13.94 $0.00 $18.54 $14.48 ($5.09) $19.43 $14.95 $15.30 ($5.06)
Total Capital
62,855 64,794 0.00 68,091 68,665 69,763 71,431 72,343 72,698 73,570
Total Debt
38,273 40,050 0.00 43,012 43,195 44,008 45,370 46,191 46,076 46,649
Total Long-Term Debt
35,283 35,662 0.00 40,271 39,821 40,082 42,661 43,429 44,091 43,337
Net Debt
36,853 38,845 0.00 41,940 42,214 42,830 43,898 44,457 44,629 45,461
Capital Expenditures (CapEx)
0.00 1,968 1,881 1,804 1,855 1,843 1,765 1,699 1,695 1,936
Debt-free, Cash-free Net Working Capital (DFCFNWC)
138 140 0.00 1,513 1,358 1,185 1,737 1,580 1,456 1,187
Debt-free Net Working Capital (DFNWC)
1,328 1,113 0.00 2,347 2,093 2,112 2,946 3,044 2,624 2,085
Net Working Capital (NWC)
-1,662 -3,275 0.00 -394 -1,281 -1,814 237 282 639 -1,227
Net Nonoperating Expense (NNE)
214 0.00 252 237 325 322 359 380 410 373
Net Nonoperating Obligations (NNO)
36,853 38,845 0.00 44,070 42,214 42,830 43,898 44,457 44,629 45,461
Total Depreciation and Amortization (D&A)
825 854 860 867 889 890 880 894 909 913
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.73% 0.00% 0.00% 0.00% 5.45% 7.82% 6.95% 6.35% 5.15%
Debt-free Net Working Capital to Revenue
0.00% 5.83% 0.00% 0.00% 0.00% 9.72% 13.27% 13.38% 11.45% 9.05%
Net Working Capital to Revenue
0.00% -17.17% 0.00% 0.00% 0.00% -8.35% 1.07% 1.24% 2.79% -5.33%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.62 $0.66 $0.45 $0.70 $0.00
Adjusted Weighted Average Basic Shares Outstanding
988M 986M 995M 995M 996M 996M 1B 1.00B 1.00B 1.00B
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.62 $0.66 $0.45 $0.70 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
989M 987M 996M 996M 997M 997M 1.00B 1.00B 1.00B 1.00B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.62 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.30B 1.30B 1.30B 1.30B 1.30B 1.31B 1.31B 1.31B 1.31B 1.31B
Normalized Net Operating Profit after Tax (NOPAT)
890 0.00 921 580 1,025 938 1,015 828 1,114 1,020
Normalized NOPAT Margin
18.37% 0.00% 16.56% 12.05% 17.14% 17.48% 16.79% 15.44% 18.11% 18.65%
Pre Tax Income Margin
15.85% 0.00% 14.43% 8.63% 12.83% 13.34% 11.93% 9.21% 12.30% 12.71%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
3.10 0.00 2.95 1.97 2.76 2.58 2.54 2.02 2.53 2.49
NOPAT to Interest Expense
2.44 0.00 2.24 1.36 2.35 2.07 2.17 1.71 2.25 2.18
EBIT Less CapEx to Interest Expense
3.10 0.00 -1.62 -2.25 -1.49 -1.49 -1.23 -1.49 -0.89 -1.66
NOPAT Less CapEx to Interest Expense
2.44 0.00 -2.33 -2.87 -1.90 -2.00 -1.60 -1.80 -1.17 -1.96
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 61.45% 0.00% 0.00% 0.00% 61.56% 62.84% 60.98% 61.80% 61.95%
Augmented Payout Ratio
0.00% 61.45% 0.00% 0.00% 0.00% 61.56% 62.84% 60.98% 61.80% 61.95%

Frequently Asked Questions About Exelon's Financials

When does Exelon's fiscal year end?

According to the most recent income statement we have on file, Exelon's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Exelon's net income changed over the last 9 years?

Exelon's net income were at $2.46 billion at the end of 2024, a 5.7% increase from 2023, and a 47.4% increase since 2015.

What is Exelon's operating income?
Exelon's total operating income in 2024 was $4.32 billion, based on the following breakdown:
  • Total Gross Profit: $9.41 billion
  • Total Operating Expenses: $5.09 billion
How has Exelon revenue changed over the last 9 years?

Over the last 9 years, Exelon's total revenue changed from $11.05 billion in 2015 to $23.03 billion in 2024, a change of 108.4%.

How much debt does Exelon have?

Exelon's total liabilities were at $80.86 billion at the end of 2024, a 6.3% increase from 2023, and a 18.8% increase since 2015.

How much cash does Exelon have?

In the past 9 years, Exelon's cash and equivalents has ranged from $357 million in 2024 to $6.50 billion in 2015, and is currently $357 million as of their latest financial filing in 2024.

How has Exelon's book value per share changed over the last 9 years?

Over the last 9 years, Exelon's book value per share changed from 21.19 in 2015 to 0.00 in 2024, a change of -100.0%.

Remove Ads


This page (NASDAQ:EXC) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners